Take part in a paid clinical trial

This study is looking at an investigational oral drug for people living with obesity or overweight.

Obesity is a chronic disease that is estimated to affect ~880 million adults globally. Adults living with obesity and overweight are at higher risk for other health problems. For some people, medicines are recommended to support weight management; however, more treatment options are needed to treat this chronic disease.

The investigational drug is an oral tablet that is designed to help people feel full sooner and reduce feelings of hunger, which may help people eat less over time.

This clinical study is investigating a potential new treatment for Alzheimer’s disease. Alzheimer’s disease is the most common cause of dementia worldwide and affects memory, thinking, and the ability to carry out everyday activities.

Over time, an abnormal protein builds up develop in the brain, which damage nerve cells and lead to worsening symptoms. Alzheimer’s disease places a growing burden on individuals, families, and healthcare systems.

While some medicines are currently approved that can help slow the progression of the disease, there is still a strong need for further research into new and improved treatments.

The study medicine is a laboratory‑made antibody designed to attach to a protein linked to Alzheimer’s disease. It is designed to enter the brain more easily, which may allow it to work at lower doses and reduce some brain‑related side effects.

We’re currently looking for adults aged 18 to 65 who are experiencing androgenetic alopecia (AGA), also known as pattern hair loss, to take part in The Headline Trial.

Hair loss is common and can affect both men and women. This clinical study is investigating new approaches that may help shape future treatment options.

You don’t need a formal diagnosis to get started. If you think you may have AGA, you can begin with a quick pre-screen. This helps us assess whether you may meet the initial study requirements. Completing the pre-screen doesn’t guarantee enrolment, but it’s an important first step in seeing whether the study may be suitable for you.

By getting involved, you’ll be contributing to research that aims to improve future options for people affected by hair loss.

Inflammation is part of the body’s natural immune response. In some conditions, inflammation can become overactive and may contribute to diseases affecting the brain and other organs. The study drug is designed to work blocking a specific protein involved in inflammation, this is hoped helps reduce the release of inflammatory substances in the body. 

Research shows that ongoing inflammation can worsen damage to nerve cells in the brain, especially in conditions such as Parkinson’s disease. Similar inflammatory processes are also involved in other neurological, heart‑related, metabolic, and autoimmune disorders. 

Reducing inflammation may help protect cells and slow disease‑related damage across several of these conditions.